Postnatal latent toxoplasmosis in schizophrenia: Cognitive and psychopathological correlates

Psychiatrie

Volumn 10, Issue SUPPL. 3, 2006, Pages 66-70

  Holub, David ^a,b   Motlová, Lucie ^b,c   Rodriguez, Mabel ^c   Dragomirecká, Eva ^b,c   Preiss, Marek ^b,c   Čermák, Jan ^b,c   Ungrmanová, Martina ^c   Nechutná, Radyka ^c   Kaňková, Šárka ^b  

^a Tonna Hospital   (United Kingdom)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

Cognitive dysfunction; First episode schizophrenia; Primary and secondary prevention in schizophrenia; Psychopathology; Schizophrenia; Toxoplasma gondii

Indexed keywords

FUNGUS ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; BEHAVIOR CHANGE; COGNITIVE DEFECT; COGNITIVE REHABILITATION; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; MENTAL PERFORMANCE; NEWBORN; OUTCOME ASSESSMENT; OUTPATIENT; PERINATAL PERIOD; PERSONALITY DISORDER; PRIMARY PREVENTION; SCHIZOPHRENIA; SECONDARY PREVENTION; SEROLOGY; SYMPTOMATOLOGY; TOXOPLASMA GONDII;

EID: 33750037307     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Bachmann S, Schröder J, Bottmer C, Torrey EF, Yolken RH. Psychopathology in First-Episode Schizophrenia and Antibodies to Toxoplasma gondii. Psychopath 2005; 38:87-90.
2. Beraki S, Aronsson F, Karlsson H, Ogren SO, Kristensson K. Influenza A virus infection causes alterations in expression of synaptic regulatory genes combined with changes in cognitive and emotional behaviors in mice. Mol Psychiatry 2005; 10(3):299-308.
3. Bhopale GM. Pathogenesis of toxoplasmosis. Comp Immunol Microbiol Infect Dis 2003; 26:213-222.
4. Boronow J, Dickerson F, Stallings C, Lee B, Origoni A, Yolken R. HSV-1, CMV and Toxoplasma serology predict cognitive deficits in schizophrenia [abstract]. Schizophr Res 2002; 53:85.
5. Brown AS, Susser ES. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 2002; 8(1):51-57.
6. Brown AS, Begg M D, Gravenstein S, Schaefer CA, Wyatt RJ, Bresnahan M et al. Serologic evidence of prenatel influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004; 61(8):774:780.
7. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas V, Susser ES. Maternal exposure to toxoplasmosis and risk of schizophrenia in adult offspring. Am J Psychiatry 2005; 162:767-773.
8. Brown AS, Schaefer CA, Quesenberry CP, Liu L, Babulas V, Susser ES. Serologic Evidence of Prenatal Exposure to Toxoplasmosis in the Etiology of Schizophrenia. Abstract No. 113639. 2005 Abstract Viewer. Savannah, GA: International Congress on Schizophrenia Research.
9. Buka SL, Yolken RH, Torrey EF, Klebanoff MA, Tsuang MT. Viruses, fetal hypoxia and subsequent schizophrenia. A direct test of infectious agents using prenatal sera [abstract]. Schizophr Res 1999; 36:38.
10. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Bernstein D, Yolken RH. Maternal infections and subsequent psychosis among offspring. Arch Gen Psychiatry 2001; 58(11):1032-1037.
11. Conejero-Goldberg C, Torrey EF, Yolken RH. Herpesviruses and Toxoplasma gondii in orbital frontal cortex of psychiatric patients. Schizophr Res 2003; 60:65-69.
12. Creuzet C, Robert F, Roisin MP, Van Tan H, Benes C, Dupouy-Camet J, et al. Neurons in primary cultures are less efficiently infected by Toxoplasma gondii than glial cells. Parasitol Res 1998; 84:25-30.
13. Delgado Garcia G. Toxoplasmosis y enfermedades mentales. Rev Cubana Med Trop 1979; 31:127-131.
14. Dragomirecka E, Lenderking WR, Motlova L, Goppoldova E, Selepova P. A brief mental health outcomes measure: Translation and validation of the Czech version of the Schwartz Outcomes Scale -10. Quality of Life Reseach, 2006; 15:307-312.
15. Dragomirecká E, Bartoňová J. Pří ručka pro uživatele české verze dotazní ků kvality zivota Světové zdravotnické organizace WHOQOL-BREF a WHOQOL-100. Psychiatrické centrum Praha 2006. ISBN 80-85121-82-4.
16. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii Tachyzoites, Bradyzoites and Sporozoites and Biology and Development of Tissue Cysts. Clin Microbiol Rev Apr 1998; 267-299.
17. Flegr J, Hrdy I. Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 1994; 41:122-126.
18. Flegr J, Zitková S, Kodym P, Frynta D. Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology 1996; 113:49-54.
19. Flegr J, Havlicek J. Changes in the personality profile of young women with latent toxoplasmosis. Folia Parasitol 1999; 46:22-28.
20. Flegr J, Hrdá Š, Havlíček J. Rozdíly v osobnostním profilu biologů nakažených a nenakažených T. gondii. Remedia Klin Mikrobiol 1999.
21. Flegr J, Kodym P, Tolarova V. Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biological Psychology 2000; 53:57-68.
22. Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z. Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-controlstudy. Bmc Infectious Diseases 2002; 2:1-6.
23. Flegr J, Preiss M, Klose J, Havlíček J, Vitáková M, Kodym P. Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis? Biological Psychology 2003; 63:253-268.
24. Flegr J, Hrušková M, Hodny Z, Hanušová J. Body height, body mass index, waist-hip ratio, fluctuating asymmetry and second to fourth digit ratio in subjects with latent toxoplasmosis. Parasitology; 2005, 130:621-628.
25. Gazzinelli RT, Sher A, Cheever A, Gerstberger S, Martin MA, Dickie P. Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo. J Exp Med 1996; 183:1645-55.
26. Green MF, Neuchterlein KH, Gold JM, Batch DM, Cohen J, Essock S, Fenton WS, Frese F, Goldberg TE, Heaton RK, Keefe RSE, Kern RS, Kraemer H, Stover E, Weinberger DR, Zalcman S, Marder SR. Approaching a Consensus Cognitive Battery for Clinical Trials in Schizophrenia: The NIMH-MATRICS Conference to Select Cognitive Domains and Test Criteria, Biol Psychiatry 2004; 56:301-307.
27. Gu H, Yolken RH, Phillips M, Yang F, Bilder RM, Gilmore JH, Lieberman JA. Evidence of Toxoplasma gondii infection in recent-onset schizophrenia [abstract]. Schizophr Res 2001; 49:53.
28. Halonen SK, Lyman WD, Chiu FC. Growth and development of Toxoplasma gondii in human neurons and astrocytes. J Neuropathol Exp Neurol 1996; 55:1150-6.
29. Havlíček J, Gasova Z, Smith AP, Zvara K, Flegr J. Decrease of psychomotor performance in subjects with latent, asymptomatic' toxoplasmosis, Parasitology 2001; 122:515-520.
30. Holub D, Motlová L, Rodriguez M, Preiss M, Čermák J, Libiger J. Toxoplasma gondii u schizofrenie. Psychiatrie 2006, Psychiatrie 2006; 10(2):81-87.
31. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res 2003; 62:237-44.
32. Karlsson H, Bachmann S, Schröder J, McArthur J, Torrey EF, Yolken RH. Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia. Proc Aatl Acad Sci USA 2001; 98:4634-4639.
33. Kirch DG. Infection and autoimmunity as etiologic factors in schizophrenia: A review and reappraisal. Schizophr Bull 1993; 19:355-370.
34. Kodym P, Malý M, Svandová E, Lekatková H, Badoutová M, Vlková J, Benes C, Zástera M. Toxoplasma in the Czech Republic 1923-1999: firs cease to widespread outbreak. Int J Parasitol 2000; 30:11-18.
35. Kocher R, Kaeser HE, Wurmser P. Zur Erwachsenentoxoplasmose des ZNS. Praxis 1969; 14:427-437.
36. Kolář J, Švarzberger F, Anton J, Jíra J, Jírovec O, Bozděch V. Vztah mezi intrakraniálními kalcifikacemi a diagnostickými testy na toxoplazmózu. Cs Radiol (Czech), 23, 1969; 4:145-153.
37. Lancon C, Aghababian V, Llorca PM, Bernard D, Auquier P. An exploration of the psychometric properties of he French version of the Positive and Negative Syndrome Scale. Can J Psychiatry 1999; 44:893:900.
38. Lindenmayer JP, Grochowski S, Hyman RB. Five-factor model of schizophrenia: replication across samples. Schizophr Res 1995; 14:229-234.
39. Leweke FM, Gerth CW, Koethe D, Klosterkötter J, Ruslanova I, Krivogorsky B, et al. Antibodies to infectious agents in individuals with recent onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 2004; 254:4-8
40. Li QY, Luo XN, Li L, Tong F. Comparative study on Toxoplasma infection in patients with schizophrenia and affective disorder. Med J Wuhan Univ (Chinese) 1999; 20:222:223.
41. Libiger J. Kognitivní deficit u schizofrenie. Referát na sympoziu "Nejnovější poznatky o neurobiologii schizofrenie a současné terapeutické možnosti", Lednice, 2006.
42. Lindenmayer JP, Grochowski S, Hyman RB. Five-factor model of schizophrenia: replication across samples. Schizophr Res 1995; 14:229-234.
43. Manning JT. Digit Ratio: A Pointer to Fertility, Behavior, and Health. Rutgers University Press, New Jersey, 2002.
44. Mednick SA, Machon RA, Huttunen MO, Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988; 45:189-92.
45. Minto A, Roberts F. The psychiatric complications of toxoplasmosis. Lancet 1959; i:1180-1182.
46. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965-76.
47. Murray RM, Jones P, O'Callaghan E, Takei N, Sham P. Genes, viruses, and neurodevelopmental schizophrenia. J Psychiatr Res 1992; 26:225-35.
48. Mortensen PB, Yolken RH, Lindum B, Sorensen T, Hougaard D, Pedersen BN. Toxoplasmosis and Other Early Infections in Relation to Schizophrenia Risk. Abstract No. 115955. 2005 Abstract Viewer. Savannah, GA: International Congress on Schizophrenia Research.
49. Neuchterlein KH, Bachr DM, Gold JM, Goldberg TE, Green MF, Heaton RK. Identification of separable cognitive factors in schizophrenia. Schizophr Research 2004; 72:29-39.
50. Novotná M, Hanusova J, Klose J, Preiss, Havlicek J, Roubalová K, Flegr J. Probable neuroimmunological link between Toxoplasma and cytomegalovirus infections and personality changes in the human host. BMC Infectious Diseases 2005, 5:54.
51. Rentakallio P, Jones P, Moring J, Von Wendt L. Association between central nervous system infections during childhood and adult onset schizophrenia and other psychoses: a 28-year follow-up. Int J Epidemiol 1997; 26:837-43.
52. Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med 1976; 84(2):193-9.
53. Scott-Lennox JA, Rose RC, Mansfield AJ, Kawata A, Parasuraman TV: Defining the social continuum of quality of life. Quality of Life Research. Vol.9, No 3, 2000, s.338.
54. Skallová A, Novotná M, Kolbeková P, Gašová Z, Veselý V, Sechovská M, Flegr J. Decreased level of novelty seeking in blood donors infected with Toxoplasma. In print.
55. Suzuki Y. Host resistance in the brain against Toxoplasma gondii. J Infect Dis 2002; 185(suppl 1):S58-S65.
56. Takei N, Sham P, O'Callaghan E, Glover G, Murray RM. Schizophrenia: increased risk associated with winter city birth - a case control study in 12 regions within England and Wales. J Epidemiol Community Health 1995; 49:106-09.
57. Torrey EF, Yolken RH. Could schizophrenia be a viral zoonosis transmitted from house cats? Schizophr Bull 1995; 21:167-71.
58. Torrey EF, Rawlings R, Yolken RH. The antecedents of psychoses: a case-control study of selected risk factors. Schizophr Res 2000; 46:17-23.
59. Torrey EF, Yolken RH. Toxoplasma gondii and schizophrenia, Emerging Infectious Diseases 2003; 9:1375-1380.
60. Torrey EF, Yolken RH. Toxoplasmosis and Schizophrenia: Is the Cat in the Hat? Abstract No. 113648. 2005 Abstract Viewer. Savannah, GA: International Congress on Schizophrenia Research.
61. Wang HL, Wang GH, Li QY, Shu C, Jiang MS, Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 2006, Acta Psychiatr Scand 2006: 1-9.
62. WHOQOL Group. Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment. Psychological Medicine 1998; 28:551-558.
63. Yolken RH, Bachmann S, Rouslanova I, Lillehoi E, Ford G, Torrey EF, Schroeder J. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clinical Infectious Diseases 2001; 32:842-844.
64. Zuckerman L, Weiner I. Maternal immune activaton leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005; 39(3):311-323.